GlassScriptPhysician profile
Brittney Ong
NPI 1851027700
$3,275.15
in general payments reported to CMS, 2019-2025
24 companies · $894 in 2025
The $894 reported for 2025 was more than what 85% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $507 · 2023: $1,001 · 2024: $874 · 2025: $894.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,631 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,631.04 |
| Education | $137.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $563.87 | 2022-2025 | |
| Shield Therapeutics INC | $435.51 | 2023-2025 | Accrufer |
| Sumitomo Pharma America, INC. | $332.88 | 2023-2025 | Myfembree |
| Abbvie INC. | $237.69 | 2022-2023 | |
| Astellas Pharma US INC | $232.27 | 2023-2025 | Veozah |
| Coopersurgical, INC. | $168.14 | 2023-2025 | Paragard T 380a, Paragard T 380a |
| Organon LLC | $167.33 | 2022-2025 | Nexplanon |
| Daiichi Sankyo INC. | $130.92 | 2022-2024 | Injectafer |
| Medical Device Business Services, INC. | $122.62 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $105.56 | 2022-2024 | |
| Sage Therapeutics, LLC | $104.66 | 2025 | Zurzuvae |
| Agile Therapeutics, INC. | $99.14 | 2023-2024 | Twirla |
| Evofem Biosciences, INC. | $94.96 | 2022-2025 | Phexxi, Solosec, Phexx |
| Therapeuticsmd, INC. | $76.58 | 2022 | |
| Pfizer INC. | $76.55 | 2022-2024 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $70.84 | 2022 | |
| Exeltis, USA INC. | $66.79 | 2025 | Slynd |
| Hologic Sales and Service, LLC | $65.95 | 2024-2025 | Thinprep 2000 Processor |
| Integra Lifesciences Corporation | $35.71 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Exact Sciences Corporation | $19.88 | 2025 | The Cologuard Plus Collection Kit |
| Davol INC. | $18.16 | 2024 | Arista Ah Flexitip |
| Qiagen, LLC | $17.35 | 2022 | |
| Becton, Dickinson and Company | $16.78 | 2023 | Bd Onclarity |
| Millicent US INC | $15.01 | 2024 | Femring, Intrarosa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittney Ong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.